Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2026 Earnings Call Transcript
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2026 Earnings Call Transcript May 14, 2026Sangamo Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.07 EPS, expectations were $0.01.





